SILKSilk Road Medical Inc

Nasdaq silkroadmed.com


$ 26.91 $ -0.07 (-0.26 %)    

Monday, 24-Jun-2024 15:59:56 EDT
QQQ $ 474.01 $ -6.22 (-1.3 %)
DIA $ 394.05 $ 2.64 (0.67 %)
SPY $ 542.74 $ -1.77 (-0.33 %)
TLT $ 94.32 $ 0.38 (0.4 %)
GLD $ 215.63 $ 0.85 (0.4 %)
$ 26.9
$ 26.97
$ 0.00 x 0
$ 0.00 x 0
$ 26.83 - $ 26.97
$ 6.08 - $ 33.78
2,366,300
na
1.06B
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-02-2020 12-31-2019 10-K
19 11-13-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 lake-street-downgrades-silk-road-medical-to-hold-lowers-price-target-to-275

Lake Street analyst Frank Takkinen downgrades Silk Road Medical (NASDAQ:SILK) from Buy to Hold and lowers the price target f...

Core News & Articles

- SEC Filing

 boston-scientific-adds-stroke-prevention-to-vascular-portfolio-via-silk-road-medicals-13b-deal

Boston Scientific to acquire Silk Road Medical for $1.26 billion, enhancing its vascular portfolio with Silk Road's TCAR sy...

Core News & Articles

Boston Scientific expects to complete the transaction in the second half of 2024, subject to customary closing conditions. Sil...

Core News & Articles

The per share price represents an approximate 38% premium to the volume-weighted average share price of Silk Road Medical's...

 jp-morgan-maintains-neutral-on-silk-road-medical-raises-price-target-to-21

JP Morgan analyst Robbie Marcus maintains Silk Road Medical (NASDAQ:SILK) with a Neutral and raises the price target from $1...

 piper-sandler-maintains-neutral-on-silk-road-medical-raises-price-target-to-20

Piper Sandler analyst Adam Maeder maintains Silk Road Medical (NASDAQ:SILK) with a Neutral and raises the price target from ...

 silk-road-medical-q1-2024-gaap-eps-036-beats-040-estimate-sales-48484m-beat-44676m-estimate

Silk Road Medical (NASDAQ:SILK) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0...

 reported-earlier-genesis-medtech-collaborates-with-silk-road-medical-to-combat-stroke-risk-in-china-with-advanced-tcar-technology

TCAR (Transcarotid Artery Revascularization) is an innovative minimally invasive surgical procedure used to treat carotid arter...

 argus-research-upgrades-silk-road-medical-to-buy-announces-24-price-target

Argus Research analyst Steve Silver upgrades Silk Road Medical (NASDAQ:SILK) from Hold to Buy and announces $24 price target.